EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair: Results From the EXPANDed Studies

Mark J Ricciardi iD, Gagan Singh iD, Jason H Rogers iD, Tobias Ruf iD, Wolfgang Rottbauer, Patrick Horn iD, Paul Mahoney, Bassem Chehab iD, Federico M Asch iD, Jose Zamorano iD, Matthew J Price iD, M Andrew M Morse iD und 8 weitere

Circulation: Cardiovascular Interventions · 2026

DOI: 10.1161/circinterventions.125.015883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, 2026. Verfasst von Mark J Ricciardi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Endeavor Health Northshore Cardiovascular Institute, Evanston, IL (M.J. Ricciardi). Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Atrial Function, Left, Mitral Valve, Atrial Remodeling. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Atrial secondary mitral regurgitation (aSMR) is a distinct subtype of SMR characterized by normal leaflets, annular dilatation, left atrial (LA) enlargement, and preserved left ventricular function. Treatment pathways for aSMR are undefined, and limited data exist regarding outcomes following mitral transcatheter edge-to-edge repair (MTEER). The analysis aimed to evaluate outcomes in patients with aSMR treated with MTEER from the EXPANDed (Evaluation of the MitraClip X System Post-MArket Real-World CliNical Outcomes Database ) studies. METHODS: One-year outcomes were assessed in patients from the EXPANDed studies (EXPAND and EXPAND G4 [Evaluation of the MitraClip X System Post-MArket Real-World CliNical Outcomes Database Generation 4 ]) who met criteria for aSMR. aSMR was defined by the presence of atrial fibrillation, left ventricular ejection fraction ≥45%, and at least 1 dilated LA parameter per echocardiographic core laboratory assessment: LA volume index, LA diameter, or LA diameter index. RESULTS: Of the 967 patients with SMR treated with MTEER in the EXPANDed data set, 160 (17%) met criteria for aSMR. Patients with aSMR were elderly (78±8 years), symptomatic (Kansas City Cardiomyopathy Questionnaire Overall Summary score, 48±27 pts), and had small left ventricular and large LA dimensions at baseline. Acute procedural success was achieved in 97.5% of patients with aSMR, with MR reduction to ≤1+ in 95.2% at 1 year. There were significant 1-year improvements in quality of life (+19 pt Kansas City Cardiomyopathy Questionnaire Overall Summary) and functional capacity (New York Heart Association I/II 80%). The 1-year all-cause mortality rate was 9%, with patients experiencing a 56% reduction in 1-year heart failure hospitalization rates from pre- to post-MTEER. CONCLUSIONS: In the largest population of patients with aSMR assessed by an echocardiographic core laboratory, MTEER safely and significantly reduced MR with improvements in quality of life and reduction in heart failure hospitalization through 1 year.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyAtrial Function, LeftMitral ValveAtrial RemodelingCardiac CatheterizationHeart Valve Prosthesis ImplantationHumansTreatment OutcomeFemaleAgedRecovery of FunctionTime FactorsMaleAged, 80 and overDatabases, FactualRisk FactorsVentricular Function, LeftQuality of LifeStroke Volume

Stichwörter der Autor:innen

atrial fibrillationdilatationechocardiographyprognosisquality of life

Autor:innen und Institutionen

  • Endeavor Health Northshore Cardiovascular Institute, Evanston, IL (M.J. Ricciardi).
  • University of Chicago Pritzker School of Medicine, Chicago, IL (M.J. Ricciardi).
  • University of California-Davis, Sacramento (G.S., J.H.R., R.S.v.B.).
  • University Medical Center of the Johannes Gutenberg-University Mainz, Germany (T.R.).
  • Ulm University Heart Center, Germany (W.R.).
  • University Hospital Dusseldorf, Germany (P.H.).

ORCID-Profile: Mark J Ricciardi, Gagan Singh, Jason H Rogers, Tobias Ruf, Patrick Horn, Bassem Chehab, Federico M Asch, Jose Zamorano, Matthew J Price, M Andrew M Morse, Paolo Denti, Francesco Maisano, Ralph Stephan von Bardeleben, Saibal Kar

Zitieren

APA

Ricciardi, M. J., Singh, G., Rogers, J. H., Ruf, T., Rottbauer, W., Horn, P., Mahoney, P., Chehab, B., Asch, F. M., Zamorano, J., Price, M. J., Morse, M. A. M., Rinaldi, M. J., Denti, P., Dong, M., Huang, R., Maisano, F., von Bardeleben, R. S., Rodriguez, E., & Kar, S. (2026). Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair: Results From the EXPANDed Studies. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.125.015883

Vancouver

Ricciardi MJ, Singh G, Rogers JH, Ruf T, Rottbauer W, Horn P, et al. Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair: Results From the EXPANDed Studies. Circulation: Cardiovascular Interventions. 2026. doi:10.1161/circinterventions.125.015883

BibTeX
@article{Ricciardi2026,
  author = {Ricciardi, Mark J and Singh, Gagan and Rogers, Jason H and Ruf, Tobias and Rottbauer, Wolfgang and Horn, Patrick and Mahoney, Paul and Chehab, Bassem and Asch, Federico M and Zamorano, Jose and Price, Matthew J and Morse, M Andrew M and Rinaldi, Michael J and Denti, Paolo and Dong, Melody and Huang, Rong and Maisano, Francesco and von Bardeleben, Ralph Stephan and Rodriguez, Evelio and Kar, Saibal},
  title = {Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair: Results From the EXPANDed Studies},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2026},
  doi = {10.1161/circinterventions.125.015883}
}
Kostenlos starten →